Anti-CD19 CAR-T cell therapy for acquired hemophilia A
Last Updated: Tuesday, May 13, 2025
A case report about a patient with immunosuppressive therapy–resistant acquired hemophilia A with intractable bleeding who achieved complete remission after autologous anti-CD19 CAR-T cell therapy.
Advertisement
News & Literature Highlights